Production (Stage)
CG Oncology, Inc.
CGON
$25.46
-$0.40-1.55%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -103.45% | -92.07% | -101.19% | -86.39% | -95.38% |
| Total Depreciation and Amortization | 500.00% | -100.00% | 425.00% | 75.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 783.50% | 1,031.34% | 153.70% | -154.89% | -330.64% |
| Change in Net Operating Assets | 105.59% | 89.40% | 932.47% | 812.59% | -2,351.21% |
| Cash from Operations | -12.55% | -41.09% | -69.60% | -71.75% | -225.72% |
| Capital Expenditure | -33.33% | -- | 133.33% | -366.67% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 39.25% | -28.45% | 159.52% | -393.67% | -290.64% |
| Cash from Investing | 39.25% | -29.80% | 159.59% | -393.86% | -290.66% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 100.00% | 100.00% | 56.18% |
| Issuance of Common Stock | -99.83% | 85,172.52% | 1,760.09% | -33.91% | 597,561.76% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 93.15% | 100.00% | -- | -- | -- |
| Cash from Financing | -99.89% | 7,814.57% | 127.10% | 100.50% | 52,735.03% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -411.55% | 10,745.59% | 461.30% | -935.43% | 179.13% |